This study assessed the diagnostic efficacy of selected blood-based biomarkers, including GFAP, NF-L, NT-proBNP, copeptin, neutrophils (%), NLR, and platelet counts, in differentiating IS and HS in the hyperacute phase of stroke. This evidence concerns the gene AVP and Stroke.